Review Article | Published:

Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Nature Reviews Rheumatology volume 13, pages 348358 (2017) | Download Citation

Abstract

Today, we are facing a new era of digitization in the health care system, and with increased access to health care information has come a growing demand for safe, cost-effective and easy to administer therapies. Dietary habits have a crucial influence on human health, affecting an individual's risk for hypertension, heart disease and stroke, as well as influencing the risk of developing of cancer. Moreover, an individual's lifestyle choices can greatly influence the progression and manifestation of chronic autoimmune rheumatic diseases. In light of these effects, it makes sense that the search for additional therapies to attenuate such diseases would include investigations into lifestyle modifications. When considering the complex web of factors that influence autoimmunity, it is not surprising to find that several dietary elements are involved in disease progression or prevention. In this Review, several common nutritional components of the human diet are presented, and the evidence for their effects on rheumatic diseases is discussed.

Key points

  • Dietary habits have long been known to have a crucial influence on human health and diseases

  • Novel roles of dietary factors in the complex interaction of different environmental factors in the pathogenesis of rheumatic autoimmune disease, as part of the 'mosaic of autoimmunity' concept, are now increasingly appreciated

  • Whereas salt seems to promote inflammation via various mechanisms, consumption of curcumin, spicy food (capsaicin), chocolate and red wine (resveratrol) might attenuate immune hyperactivity; consumption of fatty acids and coffee seems to have ambivalent effects on autoimmunity

  • The human gut microbiome is emerging as a key contributor to and a common denominator of the effects of these dietary compounds on the immune system and the development of immune-mediated diseases

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & The mosaic of autoimmunity. Immunol. Today 10, 123–126 (1989).

  2. 2.

    , & The role of genetic factors in autoimmune disease: implications for environmental research. Environ. Health Perspect. 107 (Suppl. 5), 693–700 (1999).

  3. 3.

    et al. Shared HLA class II in six autoimmune diseases in Latin America: a meta-analysis. Autoimmune Dis. 2012, 569728 (2012).

  4. 4.

    et al. Unravelling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med. 13, 81 (2015).

  5. 5.

    & Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 14, 479–489 (2015).

  6. 6.

    , & Defining and analyzing geoepidemiology and human autoimmunity. J. Autoimmun. 34, J168–J177 (2010).

  7. 7.

    et al. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun. Rev. 14, 670–679 (2015).

  8. 8.

    , , & Vitamin D in systemic and organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 45, 256–266 (2013).

  9. 9.

    et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann. NY Acad. Sci. 1109, 385–400 (2007).

  10. 10.

    et al. Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr. Med. Assoc. J. 12, 751–756 (2010).

  11. 11.

    & Eppur si muove: vitamin D is essential in preventing and modulating SLE. Lupus 25, 563–572 (2016).

  12. 12.

    et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann. Rheum. Dis. 69, 1155–1157 (2010).

  13. 13.

    et al. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann. NY Acad. Sci. 1109, 550–557 (2007).

  14. 14.

    & Vitamin D: a panacea for autoimmune diseases? Can. J. Physiol. Pharmacol. 93, 395–397 (2015).

  15. 15.

    , , , & Vitamin D and autoimmunity. Scand. J. Rheumatol. 45, 439–447 (2016).

  16. 16.

    et al. Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort. J. Intern. Med. 280, 375–387 (2016).

  17. 17.

    , , & Diet and upper gastrointestinal malignancies. Gastroenterology 148, 1234–1243 (2015).

  18. 18.

    , , , & Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am. J. Clin. Nutr. 102, 1347–1356 (2015).

  19. 19.

    et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. Am. J. Clin. Nutr. 102, 914–921 (2015).

  20. 20.

    , , & The Mediterranean diet, its components, and cardiovascular disease. Am. J. Med. 128, 229–238 (2015).

  21. 21.

    & The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 569–578 (2011).

  22. 22.

    , , , & Host-bacterial mutualism in the human intestine. Science 307, 1915–1920 (2005).

  23. 23.

    & A clinical update on the significance of the gut microbiota in systemic autoimmunity. J. Autoimmun. 74, 85–93 (2016).

  24. 24.

    et al. Evolution of mammals and their gut microbes. Science 320, 1647–1651 (2008).

  25. 25.

    et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).

  26. 26.

    et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17, 72–84 (2015).

  27. 27.

    et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 64, 3510–3520 (2015).

  28. 28.

    & Role of intestinal microbiota in the development of multiple sclerosis. Neurologia (in Spanish) (2015).

  29. 29.

    , , & T lymphocyte dynamics in inflammatory bowel diseases: role of the microbiome. Biomed. Res. Int. 2015, 504638 (2015).

  30. 30.

    et al. Behçet's syndrome patients exhibit specific microbiome signature. Autoimmun. Rev. 14, 269–276 (2015).

  31. 31.

    et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio 5, e01548–14 (2014).

  32. 32.

    , & Intestinal dysbiosis in systemic lupus erythematosus: cause or consequence? Curr. Opin. Rheumatol. 28, 515–522 (2016).

  33. 33.

    et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2, e01202 (2013).

  34. 34.

    et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 64, 3083–3094 (2012).

  35. 35.

    et al. Commensal microbiota influence systemic autoimmune responses. EMBO J. 34, 466–474 (2015).

  36. 36.

    et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895–905 (2015).

  37. 37.

    , , , & Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin. Exp. Immunol. 181, 323–337 (2015).

  38. 38.

    & Immuno-ecology: how the microbiome regulates tolerance and autoimmunity. Curr. Opin. Immunol. 37, 34–39 (2015).

  39. 39.

    et al. Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann. Rheum. Dis. 74, 303–310 (2015).

  40. 40.

    & Dietary factors regulate cytokines in murine models of systemic lupus erythematosus. Autoimmun. Rev. 11, 22–27 (2011).

  41. 41.

    & Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br. J. Nutr. 107 (Suppl 2), S171–S184 (2012).

  42. 42.

    et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am. J. Clin. Nutr. 80, 1137–1144 (2004).

  43. 43.

    et al. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J. Leukoc. Biol. 69, 449–457 (2001).

  44. 44.

    et al. Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis. Ann. Rheum. Dis. 76, 147–152 (2017).

  45. 45.

    , , , & Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann. Rheum. Dis. 73, 1949–1953 (2014).

  46. 46.

    et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford) 47, 665–669 (2008).

  47. 47.

    et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann. Intern. Med. 106, 497–503 (1987).

  48. 48.

    , & Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis — a double-blind placebo controlled study. Br. J. Rheumatol. 32, 982–989 (1993).

  49. 49.

    , , & Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J. Rheumatol. 27, 2343–2346 (2000).

  50. 50.

    & Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin. Arthritis Rheum. 27, 85–97 (1997).

  51. 51.

    , & Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch. Med. Res. 43, 356–362 (2012).

  52. 52.

    et al. Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus. Lupus 7, 192–197 (1998).

  53. 53.

    , , & Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor β mRNA and protein expression. J. Autoimmun. 8, 381–393 (1995).

  54. 54.

    et al. Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol. Int. 33, 2789–2796 (2013).

  55. 55.

    et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J. Rheumatol. 31, 1551–1556 (2004).

  56. 56.

    , , H, & Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in systemic lupus erythematosus. Nutr. J. 14, 82 (2015).

  57. 57.

    et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav. Immun. 59, 21–37 (2016).

  58. 58.

    , , , & A host–microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci. Rep. 5, 11276 (2015).

  59. 59.

    et al. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota. PLoS ONE 10, e0139721 (2015).

  60. 60.

    , , , & Non-esterified fatty acids profiling in rheumatoid arthritis: associations with clinical features and Th1 response. PLoS ONE 11, e0159573 (2016).

  61. 61.

    , , , & Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis. J. Rheumatol. 39, 327–333 (2012).

  62. 62.

    , , & A history of salt. Am. J. Nephrol. 14, 426–431 (1994).

  63. 63.

    & IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 122, 487–511 (2012).

  64. 64.

    et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518–522 (2013).

  65. 65.

    et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513–517 (2013).

  66. 66.

    , , & Sodium chloride, SGK1, and Th17 activation. Pflügers Arch. 467, 543–550 (2015).

  67. 67.

    & Autoimmunity: rubbing salt in the wound. Nature 496, 437–439 (2013).

  68. 68.

    & A salty taste to autoimmunity. N. Engl. J. Med. 368, 2520–2521 (2013).

  69. 69.

    et al. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J. Clin. Invest. 125, 4212–4222 (2015).

  70. 70.

    & The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin. Immunol. 25, 305–312 (2013).

  71. 71.

    et al. Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity. J. Autoimmun. 67, 90–101 (2016).

  72. 72.

    , , , & High sodium intake is associated with self-reported rheumatoid arthritis: a cross sectional and case control analysis within the SUN cohort. Medicine (Baltimore) 94, e924 (2015).

  73. 73.

    , & Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study. Rheumatology (Oxford) 54, 487–493 (2015).

  74. 74.

    et al. High sodium chloride consumption enhances the effects of smoking but does not interact with SGK1 polymorphisms in the development of ACPA-positive status in patients with RA. Ann. Rheum. Dis. 75, 943–946 (2016).

  75. 75.

    et al. A gene-based analysis of variants in the serum/glucocorticoid regulated kinase (SGK) genes with blood pressure responses to sodium intake: the GenSalt Study. PLoS ONE 9, e98432 (2014).

  76. 76.

    et al. Adaptive variation regulates the expression of the human SGK1 gene in response to stress. PLoS Genet. 5, e1000489 (2009).

  77. 77.

    et al. Some like it hot: the emerging role of spicy food (capsaicin) in autoimmune diseases. Autoimmun. Rev. 15, 451–456 (2016).

  78. 78.

    & The power of capsaicin. J. Continu. Educ. Top. Issues 11, 8–12 (2009).

  79. 79.

    & The antimicrobial properties of chile peppers (Capsicum species) and their uses in Mayan medicine. J. Ethnopharmacol. 52, 61–70 (1996).

  80. 80.

    , , , & Field evaluation of capsaicin as a rodent aversion agent for poultry feed. Pest Manag. Sci. 59, 1007–1015 (2003).

  81. 81.

    & The effectiveness of topically applied capsaicin. A meta-analysis. Eur. J. Clin. Pharmacol. 46, 517–522 (1994).

  82. 82.

    , , , & Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst. Rev. 2, CD007393 (2013).

  83. 83.

    et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin. Ther. 13, 383–395 (1991).

  84. 84.

    & Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J. Rheumatol. 19, 604–607 (1992).

  85. 85.

    , , , & Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328, 991 (2004).

  86. 86.

    , , , & Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. (Maywood) 234, 825–849 (2009).

  87. 87.

    , , , & Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Br. J. Nutr. 85, 203–211 (2001).

  88. 88.

    , & Recent advances in the study on capsaicinoids and capsinoids. Eur. J. Pharmacol. 650, 1–7 (2011).

  89. 89.

    , & Capsaicin may have important potential for promoting vascular and metabolic health. Open Heart 2, e000262 (2015).

  90. 90.

    & Spices: the savory and beneficial science of pungency. Rev. Physiol. Biochem. Pharmacol. 164, 1–76 (2013).

  91. 91.

    , & Mechanisms and clinical uses of capsaicin. Eur. J. Pharmacol. 720, 55–62 (2013).

  92. 92.

    , & Oral ingestion of capsaicin, the pungent component of chili pepper, enhances a discreet population of macrophages and confers protection from autoimmune diabetes. Mucosal Immunol. 5, 76–86 (2012).

  93. 93.

    & Neuroinflammation of the central and peripheral nervous system: an update. Clin. Exp. Immunol. 175, 333–335 (2014).

  94. 94.

    et al. Functional expression of TRPV channels in T cells and their implications in immune regulation. FEBS J. 282, 2661–2681 (2015).

  95. 95.

    & Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc. Natl Acad. Sci. USA 102, 5120–5125 (2005).

  96. 96.

    Biró, T. et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood 91, 1332–1340 (1998).

  97. 97.

    , & Sensory TRP channel interactions with endogenous lipids and their biological outcomes. Molecules 19, 4708–4744 (2014).

  98. 98.

    et al. Substance P in the serum of patients with rheumatoid arthritis. Rev. Rhum. Engl. Ed. 64, 18–21 (1997).

  99. 99.

    , , , & Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand. J. Rheumatol. 20, 326–335 (1991).

  100. 100.

    & The serum growth hormone to somatostatin ratio is skewed upward in rheumatoid arthritis patients. Front. Biosci. 9, 1660–1664 (2004).

  101. 101.

    et al. Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul. Pept. 55, 85–102 (1995).

  102. 102.

    et al. Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis. Brain Behav. Immun. 45, 50–59 (2015).

  103. 103.

    et al. Local application of capsaicin into the draining lymph nodes attenuates expression of adjuvant-induced arthritis. Neuroimmunomodulation 7, 115–125 (2000).

  104. 104.

    , , , & Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients. Rheumatol. Int. 33, 2665–2670 (2013).

  105. 105.

    & Antimicrobial functions of spices: why some like it hot. Q. Rev. Biol. 73, 3–49 (1998).

  106. 106.

    et al. Antimicrobial properties of chili peppers. J. Infect. Dis. Ther. (2014).

  107. 107.

    , & Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol. Lett. 146, 223–227 (1997).

  108. 108.

    et al. Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae. FEMS Microbiol. Lett. 306, 54–60 (2010).

  109. 109.

    et al. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J. Antimicrob. Chemother. 67, 2401–2408 (2012).

  110. 110.

    et al. Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis. Eur. J. Clin. Microbiol. Infect. Dis. 33, 211–219 (2014).

  111. 111.

    Note on capsicums. J. Pharm. Sci. 1, 453–454 (1912).

  112. 112.

    Spice Crops (CABI, 2002).

  113. 113.

    , , & Determination of capsaicin content and pungency level of five different peppers grown in Nigeria. NY Sci. J. 3, 17–21 (2010).

  114. 114.

    , , & Determination of capsaicin and dihydrocapsaicin in Capsicum fruit samples using high performance liquid chromatography. Molecules 16, 8919–8929 (2011).

  115. 115.

    & in Herbal Medicine: Biomolecular and Clinical Aspects 2nd edn Ch. 13 (ed. Wachtel-Galor, S.) 263–288 (CRC Press, 2011).

  116. 116.

    , , , & Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice. Br. J. Nutr. 110, 69–76 (2013).

  117. 117.

    , , & Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Neuropharmacology 99, 156–167 (2015).

  118. 118.

    et al. Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells. Neurosci. Lett. 626, 25–34 (2016).

  119. 119.

    et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br. J. Pharmacol. (2016).

  120. 120.

    , , & Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol. Adv. 32, 1053–1064 (2014).

  121. 121.

    & A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 26, 1719–1725 (2012).

  122. 122.

    et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J. Ren. Nutr. 22, 50–57 (2012).

  123. 123.

    et al. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm. Bowel Dis. 21, 2483–2494 (2015).

  124. 124.

    et al. The essential medicinal chemistry of curcumin. J. Med. Chem. 60, 1620–1637 (2017).

  125. 125.

    et al. Coffee consumption and mortality in the Chicago Western Electric Company Study. Am. J. Epidemiol. 126, 803–812 (1987).

  126. 126.

    et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin. Proc. 88, 1066–1074 (2013).

  127. 127.

    , , , & Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am. J. Epidemiol. 180, 763–775 (2014).

  128. 128.

    et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation 132, 2305–2315 (2015).

  129. 129.

    et al. Association of coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am. J. Epidemiol. 182, 1010–1022 (2015).

  130. 130.

    , & Immunomodulatory effects of caffeine: friend or foe? Pharmacol. Ther. 111, 877–892 (2006).

  131. 131.

    et al. Caffeine inhibits cytokine expression in lymphocytes. Cytokine 30, 177–181 (2005).

  132. 132.

    , , & Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 24, 203–217 (1992).

  133. 133.

    , & Suppressive effects of caffeine on the immune response of the mouse to sheep erythrocytes. Proc. Soc. Exp. Biol. Med. 144, 633–638 (1973).

  134. 134.

    et al. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J. Neurol. Neurosurg. Psychiatry 87, 454–460 (2016).

  135. 135.

    et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 64, 1063–1071 (2015).

  136. 136.

    , & Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis. Clin. Rheumatol. 33, 1575–1583 (2014).

  137. 137.

    et al. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann. Rheum. Dis. 59, 631–635 (2000).

  138. 138.

    et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 46, 83–91 (2002).

  139. 139.

    et al. Cardiovascular disease in Latin American patients with systemic lupus erythematosus: study and a systematic review. Autoimmune Dis. 2013, 794383 (2013).

  140. 140.

    , , , & The autoimmune ecology. Front. Immunol. (2016).

  141. 141.

    et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr. 23, 197–204 (2004).

  142. 142.

    , , & Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J. Hypertens. 21, 2281–2286 (2003).

  143. 143.

    et al. Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030–1031 (2003).

  144. 144.

    , , & Cocoa and cardiovascular health. Circulation 119, 1433–1441 (2009).

  145. 145.

    , , , & Cocoa antioxidants and cardiovascular health. Am. J. Clin. Nutr. 81 (Suppl. 1), 298S–303S (2005).

  146. 146.

    et al. The effect of cocoa procyanidins on the transcription and secretion of interleukin 1β in peripheral blood mononuclear cells. Life Sci. 66, 1377–1386 (2000).

  147. 147.

    , & Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell. Immunol. 177, 129–136 (1997).

  148. 148.

    et al. Effect of cocoa procyanidins on the secretion of interleukin-4 in peripheral blood mononuclear cells. J. Med. Food 3, 107–114 (2000).

  149. 149.

    et al. Effect of Theobroma cacao flavonoids on immune activation of a lymphoid cell line. Br. J. Nutr. 93, 859–866 (2005).

  150. 150.

    & Cocoa: antioxidant and immunomodulator. Br. J. Nutr. 101, 931–940 (2009).

  151. 151.

    et al. Effect of a cocoa flavonoid-enriched diet on experimental autoimmune arthritis. Br. J. Nutr. 107, 523–532 (2012).

  152. 152.

    , , , & In vivo inhibition of TNFα-induced vascular permeability by resveratrol. Transplant. Proc. 33, 2341–2343 (2001).

  153. 153.

    , , , & Effects of resveratrol on the rat brain respiratory chain. Drugs Exp. Clin. Res. 25, 87–97 (1999).

  154. 154.

    et al. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity. Int. J. Tissue React. 21, 93–104 (1998).

  155. 155.

    , & Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509–6519 (2000).

  156. 156.

    , & Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem. Pharmacol. 72, 1506–1515 (2006).

  157. 157.

    & Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59, 865–870 (2000).

  158. 158.

    et al. Antiplatelet activity of cis-resveratrol. Drugs Exp. Clin. Res. 22, 61–63 (1996).

  159. 159.

    , , , & Effects of resveratrol in inflammatory arthritis. Inflammation 30, 1–6 (2007).

  160. 160.

    et al. Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model. Rheumatology (Oxford) 55, 1889–1900 (2016).

  161. 161.

    et al. A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: in vivo studies. Eur. J. Pharm. Sci. 78, 163–170 (2015).

  162. 162.

    et al. Effect of sodium alginate addition to resveratrol on acute gouty arthritis. Cell. Physiol. Biochem. 36, 201–207 (2015).

  163. 163.

    et al. The effect of resveratrol on the recurrent attacks of gouty arthritis. Clin. Rheumatol. 35, 1189–1195 (2016).

  164. 164.

    et al. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 5, 1241–1249 (2014).

  165. 165.

    & The digital doctor. Harefuah 154, 148–149 (in Hebrew) (2015).

  166. 166.

    & Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med. 14, 72 (2016).

  167. 167.

    et al. The early infant gut microbiome varies in association with a maternal high-fat diet. Genome Med. 8, 77 (2016).

Download references

Author information

Affiliations

  1. The Zabludowicz Centre for Autoimmune Diseases, Chaim Sheba Medical Centre, Derech Sheba 2, Tel-Hashomer, Ramat-Gan 52621, Israel.

    • Shani Dahan
    • , Yahel Segal
    •  & Yehuda Shoenfeld
  2. Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.

    • Yehuda Shoenfeld

Authors

  1. Search for Shani Dahan in:

  2. Search for Yahel Segal in:

  3. Search for Yehuda Shoenfeld in:

Contributions

All authors researched the data for the article, provided substantial contributions to discussions of its content, wrote the article and undertook review and/or editing of the manuscript before submission. S.D. and Y. Segal share lead authorship.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Yehuda Shoenfeld.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrrheum.2017.42

Further reading